Back to Search
Start Over
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
- Source :
- Molecular Cancer, Vol 20, Iss 1, Pp 1-6 (2021), Molecular Cancer
- Publication Year :
- 2021
- Publisher :
- BMC, 2021.
- Subjects :
- Oncology
Male
Cancer Research
medicine.medical_specialty
Lung Neoplasms
MEDLINE
Biology
lcsh:RC254-282
Genetic Heterogeneity
Text mining
Internal medicine
Carcinoma, Non-Small-Cell Lung
Exome Sequencing
medicine
Carcinoma
Biomarkers, Tumor
Humans
Lung cancer
Letter to the Editor
Immune Checkpoint Inhibitors
Survival analysis
Exome sequencing
Predictive biomarker
Genetic heterogeneity
business.industry
medicine.disease
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Survival Analysis
Treatment Outcome
Molecular Medicine
Female
business
Subjects
Details
- Language :
- English
- ISSN :
- 14764598
- Volume :
- 20
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Molecular Cancer
- Accession number :
- edsair.doi.dedup.....bf6bae85bfd2c8b6248a7e0e7c13e998